BC Week In Review | Jun 16, 2014
Clinical News

EX404 regulatory update

EffRx said FDA granted Orphan Drug designation for EX404 to treat pediatric polycystic ovary syndrome (PCOS). This fall, the company plans to begin clinical testing of the effervescent formulation of metformin for oral solution. EffRx...
BC Innovations | Nov 7, 2013
Translation in Brief

Translational tidbits

The Cancer Prevention & Research Institute of Texas is back in the grant-making business after a legislated time-out to rebuild its executive leadership and sort out perceived transparency problems. Last week, Texas Gov. Rick Perry...
BC Week In Review | Oct 14, 2013
Company News

EffRx genitourinary news

The Metfizz consortium led by EffRx received a €5.9 million ($8 million) grant from the EU's Framework Programme 7 (FP7) to develop EffRx's EX404 to treat polycystic ovarian syndrome (PCOS). The consortium, which is expected...
Items per page:
1 - 3 of 3